Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01660139 · ClinicalTrials.gov registry record
Use of Alternative Medicine Among Outpatients in Dermatology and Primary Care Clinics
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 75
- Enrollment target
NCT01660139: Completed study, sponsored by Northwestern University.
NCT01660139 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01660139 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
This study is to assess the practice of complementary and alternative medicine (CAM) for skin related conditions among patients in the Primary Care and Dermatology clinics.
Primary Outcome
At the clinic appointment, patients will be given a survey that asks about whether the patient uses complementary and alternative medicine for skin related issues.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-10 |
What the finished NCT01660139 record still lists
NCT01660139 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01660139 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01660139 about?
NCT01660139 is a clinical study titled "Use of Alternative Medicine Among Outpatients in Dermatology and Primary Care Clinics". This study is to assess the practice of complementary and alternative medicine (CAM) for skin related conditions among patients in the Primary Care and Dermatology clinics.
What is the current status of trial NCT01660139?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2012-07. Estimated completion is 2015-10.
Who is sponsoring clinical trial NCT01660139?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia